Advised Charmacy Pharmaceutical Co., Ltd on its H share full circulation program and successfully applied for listing approval from SEHK

2022-06-21

Chungs Lawyers, the associated firm of DeHeng Law Offices in Hong Kong, advised Charmacy Pharmaceutical Co., Ltd (stock code:2289) ("Charmacy") on the full circulation of its H shares on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). 

On 14 June 2022, the Company has successfully applied for the approval of the listing of and permission to deal in 80,000,000 H shares of the Company (representing the maximum number of the unlisted shares of the Company) by the Stock Exchange. Upon completion, all 80,000,000 domestic shares of Charmacy will be converted into H shares for full circulation on the Main Board of the Stock Exchange.

Charmacy is a company listed on the Main Board of the Stock Exchange. Charmacy is principally engaged in pharmaceutical distribution business. 

The Partners of Chungs Lawyers, the associated firm of DeHeng Law Offices in Hong Kong, Ernest Chung and Boaz Cheung, led the team includes Crystal Wong, Chloe Yuen, Sally Lam and Elvis Lee.